Murtha-Lemekhova, A
Licensed pharmacological options that have been thoroughly evaluated for safety and efficacy include: Orlistat : A lipase inhibitor that reduces fat absorption from the diet Liraglutide (Saxenda) and semaglutide (Wegovy) : GLP-1 receptor agonists similar to tirzepatide but with more extensive long-term safety data Naltrexone-bupropion (Mysimba) : A combination medication affecting appetite and reward pathways Each of these has specific indications, contraindications, and monitoring requirements that should be discussed with a healthcare professional
As shown in Table 2, subjects in the intermediate and high UA quartiles displayed progressively higher levels of total cholesterol, triglycerides, fasting and 2 hours post-load glucose levels, fasting insulin, and homeostasis model assessment index of insulin resistance, and lower concentrations of high-density lipoprotein cholesterol in comparison to individuals in the lowest quartile of UA after adjusting for age, sex, and body mass index
[DOI] [PubMed] [Google Scholar] Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B
Authorization forms
.webp)
